Independent predictive value of blood inflammatory composite markers in ovarian cancer: recent clinical evidence and perspective focusing on NLR and PLR
C Zhang, X Jiang, Y Li, X Pan, M Gao, Y Chen… - Journal of ovarian …, 2023 - Springer
Ovarian cancer (OC) is one of the deadliest malignant tumors affecting women worldwide.
The predictive value of some blood inflammatory composite markers in OC has been …
The predictive value of some blood inflammatory composite markers in OC has been …
The prognostic role of systemic inflammatory markers in apparent early-stage ovarian cancer
N Bizzarri, M D'Indinosante, C Marchetti… - International Journal of …, 2023 - Springer
Background Few studies analyzed the prognostic role of systemic inflammatory markers in
early-stage ovarian cancer. The primary endpoint of the present study was to assess the …
early-stage ovarian cancer. The primary endpoint of the present study was to assess the …
Prognostic performance of pretreatment systemic immune-inflammation index in women with epithelial ovarian cancer
Purpose: This study investigated the prognostic performance of the systemic immune-
inflammation index (SII) in patients with epithelial ovarian cancer (EOC) in Lagos, Nigeria …
inflammation index (SII) in patients with epithelial ovarian cancer (EOC) in Lagos, Nigeria …
The utility of pre-treatment inflammation markers as associative factors to the adverse outcomes of Vulvar Cancer: a study on staging, nodal involvement, and …
Background: Given the role of inflammation in carcinogenesis, this study investigated the
utility of pre-treatment inflammatory markers as associative indicators for advanced-stage …
utility of pre-treatment inflammatory markers as associative indicators for advanced-stage …
Predictors of early mortality risk in patients with epithelial ovarian cancer
KS Okunade, S John‐Olabode… - Health science …, 2022 - Wiley Online Library
Background To improve the overall survival of epithelial ovarian cancer (EOC) patients, a
more precise risk identification after completion of standard treatment will enhance patients' …
more precise risk identification after completion of standard treatment will enhance patients' …
Clinical and molecular signature of survival and resistance to olaparib plus pegylated liposomal doxorubicin in platinum-resistant ovarian cancer: a stratified analysis …
JA Perez-Fidalgo, E Guerra, Y García… - International Journal of …, 2023 - ijgc.bmj.com
Objective To determine the potential prognostic value of clinical and molecular biomarkers
in the survival of patients with platinum-resistant ovarian cancer treated with olaparib and …
in the survival of patients with platinum-resistant ovarian cancer treated with olaparib and …
[HTML][HTML] Clinical value of serum tumor markers in assessing the efficacy of neoadjuvant chemotherapy in advanced ovarian cancer: single-center prospective clinical …
J Huang, D Du, H Chen, D Luo, Q Wang, C Li… - Frontiers in …, 2024 - ncbi.nlm.nih.gov
Objective This study aimed to assess the clinical importance of various biomarkers,
including NLR, CEA, CA199, CA125, CA153, and HE4, through dynamic testing to evaluate …
including NLR, CEA, CA199, CA125, CA153, and HE4, through dynamic testing to evaluate …
[HTML][HTML] Impact of obesity on survival outcomes of women with advanced epithelial ovarian cancer in Lagos, Nigeria: a retrospective cohort study
KS Okunade, OO Akinmola, TV Adekanye… - …, 2024 - pmc.ncbi.nlm.nih.gov
Background Epithelial ovarian cancer (EOC) is a major contributor to cancer-related illness
and death among women worldwide. Obesity, a prevalent condition in many populations …
and death among women worldwide. Obesity, a prevalent condition in many populations …
[HTML][HTML] Timing of recurrence and overall survival in epithelial ovarian cancer: a 10-year retrospective review
KS Okunade, A Soibi-Harry, T Onyeka… - Hellenic Journal of …, 2022 - hjog.org
Background: The timing of recurrence of epithelial ovarian cancer (EOC) after a standard
primary treatment is an important indicator of the degree of response of the tumour to …
primary treatment is an important indicator of the degree of response of the tumour to …
Prognostic value of neutrophil-to-lymphocyte ratio and fibrinogen levels in ovarian cancer
R Rosaudyn, F Mutian, I Yuliati, B Robby Indraprasta - 2023 - repository.unar.ac.id
Prognostic value of neutrophil-to-lymphocyte ratio and fibrinogen levels in ovarian cancer
Roudhona Rosaudyn1, Faradillah Mutiani2, Indra Yuliati1, Birama Robby Indraprasta1 …
Roudhona Rosaudyn1, Faradillah Mutiani2, Indra Yuliati1, Birama Robby Indraprasta1 …